Shots:The UK’s MHRA has approved Oczyesa (octreotide SC depot) for the maintenance treatment in adult with acromegaly who have responded to & tolerated somatostatin analogs, following EC approval on Jun 30, 2025; UK launch expected in Q4’25Approval was based on extensive data from 7 trials, incl. 4 P-I trials, 1 P-II trials &…
